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As a means of heated debate, mass vaccination of poultry has been used in some countries to control H5N1 highly pathogenic 
avian influenza (HPAI), which remains of global economic and public health significance. Theoretically, mass vaccination can act 
as an evolutionary selective force facilitating the emergence of vaccine-resistant viruses, similar to that widespread use of antibio-     
tics facilitates the emergence of antibiotic-resistant bacteria. To support the hypothesis, the substitution rates in the two subunits, 
HA1 and HA2, of the viral hemagglutinin gene, were calculated using a Bayesian Markov Chain Monte Carlo (MCMC) approach. 
It was found that the rate in the HA1 subunit, but not in the HA2 subunit, increased significantly during periods of mass vaccina-
tion (20052010 in China and 20032009 in Indonesia), in contrast to the periods when no mass vaccination programs took place 
(19962004 in China and 20042008 in Thailand). Because substitutions in the HA1 subunit rather than in the HA2 subunit can 
lead to vaccine-resistant viruses, the results support that mass vaccination programs facilitate the emergence of vaccine-resistant 
viruses, which, in turn, will render mass vaccination programs less effective. Therefore, caution must be taken when adopting 
mass vaccination as a long-term strategy to control HPAI. 
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H5N1 subtype highly pathogenic avian influenza (HPAI) 
viruses have been circulating widely in wild birds and do-
mestic fowls for years in Eurasia and Africa, despite great 
efforts to control the disease [1–4]. Consequently, the virus 
has caused huge economic loss in poultry in many affected 
countries. Furthermore, the virus has also caused hundreds 
of fatal human cases since the end of the year 2003. It may 
thus spark a human pandemic influenza, if it has adapted to 
efficient human-to-human transmission through gene muta-
tion or genetic re-assortment [1,5]. To minimize the direct 
loss caused by H5N1 HPAI, vaccination of poultry has been 
used as an important prevention and control means in China, 
Indonesia, Vietnam, Egypt, and several other countries 
[6–8]. 
Circulation of H5N1 HPAI virus in China was firstly 
identified in 1996, and was confirmed in each of the subse-
quent years [1–3,9,10]. Gene sequences of some H5N1 
HPAI viruses circulating in China in 1996–2010 have been 
available in GenBank, or reported herein. Vaccination of 
poultry against HPAI has been used in China since 2004. 
Initially, only birds in and around areas where outbreaks 
occurred were vaccinated. In 2005, mass vaccination was 
compulsorily applied to all domestic poultry. Since then, 
billions of domestic birds have been vaccinated in China 
every year [11]. 
Circulation of H5N1 HPAI virus in Indonesia was firstly 
identified in 2003, and was confirmed in each of the subse-
quent years [12]. Gene sequences of some H5N1 HPAI vi-
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ruses circulating in Indonesia in 2003–2009 have been 
available in GenBank. Large commercial poultry producers 
in Indonesia implemented vaccination against H5N1 HPAI 
using various vaccines, soon after the disease broke out in 
the country in 2003. The vaccines were also provided by the 
government free of charge to the backyard poultry sector 
from mid-2004 onwards, except that in 2006 and 2007, ef-
forts were focused on twelve high-risk provinces due to 
limited resources [6]. 
Circulation of H5N1 HPAI virus in Thailand was firstly 
identified in 2004, and was confirmed in each of the subse-
quent years till 2008 [13]. Gene sequences of some H5N1 
HPAI viruses circulating in Thailand in 2004–2008 have 
been available in GenBank. Vaccination against HPAI has 
never been approved in Thailand. 
Circulation of H5N1 HPAI virus in Vietnam was firstly 
identified in 2001, and was almost confirmed in each of the 
subsequent years [14,15]. The sequence data have revealed 
several times of introduction of exotic H5N1 viruses into 
Vietnam [14–16]. A vaccination campaign targeting flocks 
and regions of a higher risk to be infected with the deadly 
viruses started at the end of 2005 in Vietnam, and resulted 
in decline of poultry and human cases [17]. 
Circulation of H5N1 HPAI virus in Egypt was firstly 
identified in 2005, and was confirmed in each of the subse-
quent years [18]. However, the impact on disease control of 
the vaccination in Egypt has been very limited, and a recent 
assessment study highlighted substantial weaknesses in the 
vaccination programs in Egypt [19]. 
Except in Egypt, the vaccination strategy has proved to 
be effective in protecting poultry from H5N1 virus infection, 
reducing the virus load in the environment, and preventing 
the transmission of H5N1 viruses from poultry to humans, 
at least from the experience in China and Vietnam [6,11,17]. 
However, the use of mass vaccination has been the subject 
of heated debate in recent years due to its obvious negative 
effects [20–24]. Firstly, vaccination is a logistically demand-
ing and costly method [6,22,24]. Secondly, vaccination fa-
cilitates “silent” spread of the virus, because vaccinated 
birds usually show no severe clinical signs if they are in-
fected with the virus, and thus farmers may relax their vigi-
lance and relevant biosecurity measures [24]. Furthermore, 
vaccine-resistant influenza viruses, which reduce the effi-
cacy of mass vaccination programs, have been reported to 
have emerged in China, Egypt, and Indonesia [6,18,25]. 
Theoretically, in a similar manner as the widespread use 
of antibiotics facilitates the emergence of antibiotic-resistant 
bacteria strains [26], effective mass vaccination should fa-
cilitate the emergence of vaccine-resistant viruses, which 
can spread among vaccinated hosts, and thus have an ad-
vantage over the non-resistant viruses [27]. With this con-
sideration, mass vaccination programs against HPAI may 
act as an evolutionary selective force driving the substitu-
tion rate in the gene of the virus involved in vaccine re-
sistance. So far, however, no direct data have been reported 
to support this idea.  
This study aims to investigate whether the substitution 
rates in the two subunits, HA1 and HA2, of the viral hemag-
glutinin (HA) increased during periods of mass vaccination. 
HA is a glycoprotein present in the viral membrane as a 
single polypeptide (HA0), which is cleaved by the host’s 
proteases into HA1 and HA2. The HA1 subunit is the major 
surface antigen, a target of neutralizing antibodies produced 
during infection or vaccination, and substitutions in the 
HA1 subunit can result in vaccine-resistant influenza virus-
es [28,29]. In effect, as far as we know, substitutions in the 
HA1 subunit play a much more important role than those in 
the HA2 subunit in vaccine escape [18,25,30–32]. In this 
sense, the HA2 subunit serves as a control in this study 
when analyzing the substitution rate of the HA1 subunit. 
In this study, we compared the nucleotide and amino acid 
substitution rates in the HA1 and HA2 subunits in four pe-
riods: 19962004 in China, 20052010 in China, 20032009 
in Indonesia, and 20042008 in Thailand. We selected these 
four periods because mass vaccination was not implemented 
in China until 2005, and HPAI vaccination has never been 
approved in Thailand, but was implemented in Indonesia in 
2003–2009. We did not analyze the data of Egypt and Vi-
etnam, because the vaccination strategy were not well im-
plemented in Egypt, and some exotic H5N1 viruses have 
been introduced into Vietnam in the past several years for 
multiple times [14–16,19]. The substitution rate can be 
overestimated if these exotic viruses were not well identi-
fied and excluded from the calculation. In addition, many 
H5N1 HPAI viruses circulating in Vietnam might be just 
under a slight vaccination pressure as the vaccination strat-
egy in Vietnam targeted only flocks and regions of a higher 
risk to be infected with the deadly virus [17]. 
1  Materials and methods  
1.1  Sample collection 
We have reported the HA gene sequences of 55 H5N1 HPAI 
viruses isolated in 2007–2009 with GenBank accession 
numbers HM006764–HM006818 and HM583607–HM583609 
[3]. Here, we report sequences of 17 additional H5N1 HPAI 
viruses isolated in 2010 (the relevant infection information 
has been released online by Ministry of Agriculture of China, 
http://www.moa.gov.cn/zwllm/tzgg/gb/sygb/). Swab samples 
were collected by taking smears from the trachea and cloa-
cae of the domestic fowls in randomly selected live bird 
markets. The samples were clarified by centrifugation, and 
the supernatants were inoculated in specific-pathogen-free 
(SPF) chicken embryonated eggs via the allantoic sac route. 
The eggs were further incubated for 4 d. Thereafter, the 
allantoic fluids of the embryos were collected and tested 
using the hemagglutination assay. All the hemagglutina-
tion-positive samples and the allantoic fluid of the embryos 
died during the incubation, were investigated further using 
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the universal RT-PCR, which targets the whole length of the 
HA gene of all subtypes of influenza viruses [33]. PCR 
products were purified and ligated with pGEM-T Easy vec-
tor (Promega, Beijing, China). Then, both strands of the 
clones were sequenced using a Perkin-Elmer model 377 XL 
DNA sequencer. The GenBank accession numbers of the 
HA gene sequences reported herein are JF789566–JF789582. 
1.2  Representative sequence selection 
A total of 1288 nucleotide sequences (>800 bp) of the HA 
gene of H5 subtype HPAI viruses from China, Indonesia, 
and Thailand available in GenBank, or reported herein, 
were compiled using the web server of Influenza Virus Re-
source [34]. If available from these compiled sequences, 
eight full-length representative sequences were selected for 
each year in each of the countries. They were selected ap-
proximately according to phylogenetic distribution of the 
sequences, namely that more representative sequences were 
randomly selected from a bigger branch (i.e. the one cover-
ing more viruses) than from a smaller branch (i.e. the one 
covering less viruses).  
1.3  Phylogenetic analysis 
Sequences were aligned using the software MUSCLE [35]. 
Genetic distances and phylogenetic relationships under the 
GTR model were calculated with the maximum-likelihood 
method using the software MEGA 5.0 (http://www.megaso-    
ftware.net/) [36]. Bootstrap values were calculated from 
1000 replicates. Clades of H5N1 HPAI viruses were desig-
nated according to the WHO/OIE/FAO nomenclature sys-
tem [31]. 
1.4  Calculation of the substitution rate 
The substitution rate in the gene was estimated using the 
software BEAST 1.6.1 (http://evolve.zoo.ox.ac.uk/Beast/), 
which employs a sophisticated Bayesian Markov Chain 
Monte Carlo (MCMC) approach that allows for rate varia-
tion among lineages and a range of demographic histories 
[37]. Nucleotide substitution and amino acid substitution 
were set to the General Time Reversible (GTR) model and 
the Jones-Taylor-Thornton (JTT) model, respectively [38]. 
The software was run using the Bayesian skyline plot under 
the uncorrelated exponential relaxed-clock model. A previ-
ous analysis of human influenza A virus evolution found 
that the uncorrelated exponential relaxed clock model pro-
vided a better fit to the data than the uncorrelated lognormal 
model [37], and this was further confirmed by Chen and 
Holmes in analyses of the data of avian influenza viruses 
[39], although the parameter values estimated were similar 
under both models. Each analysis was run at least four times 
(10 million chain lengths for each time) to check conver-
gence of the Markov chain to the posterior distribution.  
2  Results 
2.1  Representative sequence selection 
Nucleotide sequences (>800 bp) of the HA gene of a total of 
1288 (844 from China, 171 from Indonesia, 273 from Thai-
land) H5 subtype HPAI viruses were available in GenBank 
on March 20, 2011, or reported herein. From them, 168 
HA1 representative sequences (44 for 1996–2004 in China, 
48 for 2005–2010 in China, 36 for 2003–2009 in Indonesia, 
40 for 2004–2008 in Thailand), and 163 HA2 representative 
sequences (42 for1996–2004 in China, 47 for 2005–2010 in 
China, 36 for 2003–2009 in Indonesia, 38 for 2004–2008 in 
Thailand) were selected. Their designations and phyloge-
netic relationships are given in Figures S1 and S2, which 
were largely consistent with each other, and consistent with 
the global phylogenetic distribution of H5N1 HPAI viruses 
in recent years [31]. All the representative sequences were 
involved in the subsequent substitution rate analysis, except 
three from Thailand and one from Indonesia, which, as 
shown in Figure S1, were not indigenous in these two coun-
tries. Similar exotic sequences were excluded as representa-
tives for HA2, and thus they were not covered in Figure S2. 
The selected representatives covered all known major clades 
circulating during the relevant periods in the three countries 
[1–3,9,10,13,31]. It should be noted that full-length se-
quences of some H5N1 HPAI viruses were not available for 
both HA1 and HA2 in GenBank, and the HA1 and HA2 
representative sequences were selected at random, respec-
tively. Therefore, the HA1 and HA2 representative sequences 
selected in this study are not always from the same viruses. 
In addition, not as much as eight representative sequences 
were selected for each of the years in each of the countries, 
because inadequate candidates of relevant years in relevant 
countries were available in GenBank. 
2.2  Changes in substitution rates in HA1 and HA2 
Table 1 summarizes the substitution rates in the HA1 and 
HA2 subunits calculated in this study using the aforemen-
tioned representative sequences. For the two data sets where 
mass vaccination was implemented, China 2005–2010 and 
Indonesia 2003–2009, the substitution rates in both nucleo-
tide sequences and amino acid sequences of the HA1 subunit, 
were substantially higher than their counterparts for China 
1996–2004 and Thailand 2004–2008, where no mass vac-
cination took place. The difference in substitution rates of 
the HA1 subunit between the vaccinated versus the non- 
vaccinated data sets is statistically significant, because their 
95% highest posterior density (HPD) intervals do not over-
lap (Table 1). In contrast, Table 1 also shows that the sub-
stitution rates in both nucleotide sequences and amino acid 
sequences of the HA2 subunit did not increase significantly 
during periods of mass vaccination (China 2005–2010 and 
Indonesia 2003–2009), as compared with their counterparts  
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HA2 amino acid 
substitution rate 
Mean 95% HPD  Mean 95% HPD  Mean 95% HPD  Mean 95% HPD 
China 20052010 Yes 7.28 5.119.41  10.31 6.8513.88  3.97 2.665.25 2.55 1.263.95 
Indonesia 20032009 Yes 7.75 6.019.58  8.67 5.9211.50  4.37 3.015.71 2.03 0.80–3.40 
China 19962004 No 3.37 2.374.32  3.52 1.985.17  2.34 1.373.34 2.31 1.163.52 
Thailand 20042008 No 2.69 1.783.62  3.65 1.955.60  2.44 1.463.47 1.23 0.222.25 
 
during periods when no mass vaccination programs took 
place (China 1996–2004 and Thailand 2004–2008). The 
difference in substitution rates of the HA2 subunit between 
the vaccinated versus the non-vaccinated data sets is of no 
marked difference as their intervals of 95% HPD over-
lapped. 
2.3  Evaluation of sampling error 
The substitution rates in HA1 and HA2 subunits were cal-
culated using another set of representative sequences which 
were selected according to the same criteria stated above, 
and the results were quite similar to the data given above for 
the same gene during the same period in the same country 
(data not shown). Therefore, the sampling error can be ex-
cluded as the possible main reason for the significant in-
crease in the substitution rate of the HA1 subunit observed 
in this study, which is consistent with a previous report also 
targeting the substitution rate of genes of avian influenza 
viruses [39]. 
3  Discussion 
The data of this study suggest that the substitution rate of 
the H5N1 HPAI virus in the HA1 subunit, but not in the 
HA2 subunit, increased significantly during periods of mass 
vaccination, in contrast to the periods when no mass vac-
cination programs took place. Because substitutions in the 
HA1 subunit play a much more important role than those in 
the HA2 subunit in vaccine escape, the results support the 
idea that mass vaccination, as an evolutionary selective 
force, facilitates the emergence of vaccine-resistant viruses. 
This is also consistent with previous reports that many amino 
acid substitutions in the HA1 subunit of H5N1 HPAI virus-
es occurred at antigenic sites [3,25,40]. In addition, it has 
also been found by others that the substitution rate of virus-
es may be elevated by selection of immune escape [41,42]. 
As mass vaccination programs should lose efficacy with 
the emergence of vaccine-resistant strains, caution must be 
taken when adopting mass vaccination as a long-term strat-
egy to control HPAI. Other control measures, such as en-
hancing biosecurity of poultry systems, should be strength-
ened to combat the disease. 
The ratio of the synonymous substitution rate (dS) versus 
the non-synonymous substitution rate (dN) is widely used as 
an indicator of selective pressure acting on a protein-coding 
gene [43,44]. Homologous genes of the dN/dS ratio =1, >1 
or <1 are usually assumed to be evolving under neutral 
evolution, negative selection or positive selection, respec-
tively. We have estimated the dN/dS ratio of the two subu-
nits using the representative sequences selected in this study 
(data not shown). However, we did not find that the dN/dS 
ratio increased significantly in either of the subunits during 
the periods of mass vaccination. This may result from that 
the ratio is of a very high background of negative selection 
(i.e. dS is usually much larger than dN), and dS may be also 
elevated through hitch-hiking when dN is driven faster by a 
positive selection pressure [45]. Therefore, the dN/dS ratio 
may be not sensitive to a positive selection pressure, which 
has also been identified by our previous study on the HA1 
subunit of human H3N2 subtype influenza viruses [46]. 
Chen and Holmes [39] also found that the dN/dS ratios of 
the HA gene of mammalian influenza A viruses and avian 
influenza A viruses are not significantly higher than their 
counterparts of the neuraminidase (NA) gene, though the 
HA gene is widely thought to be under more positive selec-
tion pressure than the NA gene. 
It would be interesting to know whether the substitution 
rate in another gene of H5N1 HPAI viruses also increased 
during the mass vaccination periods. However, such work 
was hindered either by inadequate sequences available in 
GenBank, or by the frequent gene re-assortment between 
H5N1 HPAI viruses and other avian influenza viruses 
[10,12,47–51]. Some re-assortment activities involving sim-
ilar sequences cannot be easily identified through phyloge-
netic analysis, and the substitution rate may be overesti-
mated if some re-assortment activities are ignored in the 
estimation. Nevertheless, more data in the future are favored 
to support the suggestion of this report that H5N1 mass 
vaccination programs in poultry drive the substitution rate 
in the HA1 subunit of the viral HA gene, and facilitate the 
emergence of vaccine-resistant viruses, which, in turn, will 
render mass vaccination programs less effective. 
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Figure S1  Phylogenetic relationships of the selected HA1 representative sequences. 
Figure S2  Phylogenetic relationships of the selected HA2 representative sequences. 
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